Get the App
A

Aeglea Biotherapeutics (AGLE)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Aeglea Biotherapeutics (AGLE)

Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology company. It is focused on human enzyme therapeutics to treat people with rare metabolic diseases. Its lead product candidate is pegzilarginase, which is a recombinant human arginase 1 tha... Read more

  • USD0.31
  • USD0.31
  • USD0.29
  • USD3.17
  • -25.30%
  • 2M
  • 215.34k
  • 202.01k
  • 22M
  • 0.29
  • -87.40%

Stock News

: Virgin Orbit stock plunges after report says company will cease operations

1 hour ago

: Virgin Orbit stock plunges after report says company will cease operations

MarketWatch

: Donald Trump reportedly indicted in Stormy Daniels case — first former U.S. president to ever be criminally charged

1 hour ago

: Donald Trump reportedly indicted in Stormy Daniels case — first former U.S. president to ever be criminally charged

MarketWatch

NY grand jury indicts Trump in hush money payment case

1 hour ago

NY grand jury indicts Trump in hush money payment case

CNBC

Earnings Results: Shares of right-wing social platform Rumble rally nearly 30% following Q4 results

1 hour ago

Earnings Results: Shares of right-wing social platform Rumble rally nearly 30% following Q4 results

MarketWatch

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium